UBE2C and hepatocellular carcinoma: For instance, the lower UBE2C expression level indicated higher sensitivity for the therapy of chemotherapeutic drug, including adriamycin and 5-fluorouracil, and knockdown of UBE2C also increased the sensitivity of hepatocellular carcinoma cell to sorafenib [41].